MSKCC in the News: February 14 – February 20

  • Westchester Medical Center (WMC) has announced the opening of its new 5,300-square-foot outpatient Infusion Center, ushering in a new partnership with MSKCC, whose staff will provide outpatient cancer care and infusion services.
  • Dr. Michael J. Morris of MSKCC was quoted in a New York Times article about a new study that found that men with high-risk prostate cancer treated with only 18 months of hormone therapy live just as long as those treated for a more standard 36 months.